What Causes High Hematocrit On TRT (And Why It Matters)

High hematocrit on TRT happens because testosterone signals your bone marrow to make more red blood cells. That process, called erythropoiesis, raises the share of your blood made up of red cells, and it tends to show up on lab work within the first few months of starting testosterone replacement therapy (Fink et al., 2025). It's one of the most common effects of treatment, and for many men it can be managed with monitoring rather than being a reason to stop.

Still, a rising number can be unsettling, especially when a provider flags it.

High hematocrit on TRT is an above-range red blood cell percentage that develops when testosterone therapy stimulates red cell production. Hematocrit measures the portion of blood made up of red cells. Levels often climb past the usual male range during treatment, and guidelines call for action once hematocrit passes 54 percent (Bhasin et al., 2018; Mulhall et al., 2018).

This guide covers what drives the increase, when it actually matters, and how it gets handled. Marek Health reads it the way the evidence supports: watch the number alongside your blood pressure, and treat the trend instead of reacting to one reading.

What Is Hematocrit, and What Counts as "High"?

Hematocrit is the percentage of your blood volume made up of red blood cells. The higher the number, the more red cells packed into each drop.

Reference ranges vary by lab, so what counts as high is best interpreted by your provider rather than read off a result on your own. On testosterone, levels often run higher than before, and a value above 54 percent is the point most clinical guidelines treat as a signal to act (Bhasin et al., 2018; Mulhall et al., 2018).

A single reading slightly above range is often not a cause for alarm, but any high result should be reviewed by your provider alongside your symptoms and overall health. A repeat test is usually the next step.

One distinction is worth keeping straight. Hematocrit and free and total testosterone measure different things. Your testosterone level tells you whether the dose is in range. Your hematocrit tells you how your blood is responding to it.

Why TRT Pushes Hematocrit Up

Testosterone raises hematocrit by stimulating erythropoiesis, the bone marrow's production of red blood cells (Fink et al., 2025). The effect usually appears within the first few months and can keep building for up to a year.

How much it rises depends largely on which testosterone you take and how you take it. In a 2025 retrospective study of 247 men on testosterone therapy, hematocrit rose by an average of about 4 percentage points among those with paired readings before and after treatment, and by roughly 6 points in men on long-acting injectable testosterone undecanoate (Neidhart et al., 2025). By the last follow-up, 57 percent had crossed a hematocrit of 46 percent, 23 percent had passed 50 percent, and 5 percent had gone above 54 percent.

Timing matters too. Among the men who crossed a hematocrit of 46 percent, 46 percent hit their highest reading within the first year (Neidhart et al., 2025). That's why early monitoring isn't optional.

How testosterone is delivered strongly influences the size of the rise. Injectable testosterone, especially short-acting forms, tends to raise hematocrit more than transdermal creams, which hold levels steadier (Fink et al., 2025). If your hematocrit runs high on injections, a different injectable or oral formulation may behave differently.

Sources: (Fink et al., 2025; Neidhart et al., 2025)

Beyond formulation, higher doses and older age are recognized risk factors. A higher BMI and a higher starting hematocrit also raised the odds in study data (Neidhart et al., 2025). Sleep apnea and smoking matter too, since both already nudge red cell production upward.

Does a High Hematocrit on TRT Cause Blood Clots?

A very high hematocrit can contribute to clotting risk, which is the basis for the standard concern. More red cells make blood thicker and slower to move, and red cell overproduction has been linked to clots and events like stroke, heart attack, and pulmonary embolism (Fink et al., 2025).

The relationship is messier than "thick blood equals clot," though. In the TRAVERSE trial, the largest cardiovascular safety study of testosterone, 5,246 men with low testosterone and heart risk used either testosterone or placebo. Major cardiac events came out about even, 7.0 percent on testosterone versus 7.3 percent on placebo (Lincoff et al., 2023).

The same trial flagged something important. The testosterone group had more pulmonary embolism (0.9 versus 0.5 percent) and more atrial fibrillation (3.5 versus 2.4 percent) (Lincoff et al., 2023). So clots weren't the headline cardiac risk, yet they weren't absent either.

Where Blood Pressure Enters the Picture

Blood pressure is the piece that gets less attention. In February 2025, the FDA removed the cardiovascular boxed warning from testosterone labeling and, at the same time, added a new warning about increased blood pressure across the entire drug class (FDA, 2025).

That shift matters. It points to blood pressure, not only clotting, as something to watch. The blood-pressure signal is driven by testosterone, and higher red cell levels may affect circulation as well, so providers often monitor both. High blood pressure is a well-established driver of stroke and heart attack.

Testosterone itself stays approved only for men with low testosterone tied to a medical condition, not for aging (FDA, 2025). Within that lane, the real risk picture is less about one scary hematocrit reading and more about the combination of blood markers and blood pressure over time.

What a Rising Reading Actually Means for You

How urgent a rising reading is depends on the full picture, not the number alone. A hematocrit that climbs while your blood pressure stays controlled is generally viewed differently than one where both are rising, and your blood pressure before treatment factors in. Your provider is best placed to weigh these and decide whether anything needs to change.

This is where a provider who tracks the pattern earns their keep. The aim is to read hematocrit alongside cardiovascular markers, then adjust based on your labs and provider evaluation rather than a fixed rule.

When Higher Hematocrit Reflects Corrected Anemia

Not every increase is a problem. For men who were anemic before starting, testosterone can bring red blood cell counts back toward normal, which may improve oxygen delivery rather than threaten it (Fink et al., 2025).

That's the flip side of the same mechanism. The bone marrow signal that can overshoot into erythrocytosis is the same one that corrects a deficiency. Context decides whether a higher number is a benefit or a flag, which is one more reason a single reading rarely tells the whole story.

How Do You Lower Hematocrit on TRT?

If hematocrit climbs above 54 percent, guidelines call for action, and there are several standard options (Bhasin et al., 2018; Mulhall et al., 2018). Below that line, close monitoring is often all that is needed.

Depending on the situation, a provider may consider one or more of these options, in an order that fits the individual:

1. Lower the dose. Often the simplest fix, and frequently enough on its own.

2. Switch formulation. Moving from injections toward a transdermal option can reduce the rise.

3. Therapeutic phlebotomy. A blood draw is sometimes used to bring the level down, though its role is individualized and still debated.

4. Address contributors. Treating sleep apnea, cutting smoking, and managing blood pressure all help.

5. Pause if needed. Temporarily holding therapy until the level normalizes, then resuming at a lower dose.

Which option fits depends on your labs and your provider's evaluation, not a fixed formula. These are provider decisions, not changes to make on your own.

How Often Should You Check Hematocrit?

Guidelines suggest checking hematocrit before starting testosterone, again at three to six months, then once a year if levels are stable (Bhasin et al., 2018). Borderline values, dose changes, or risk factors like sleep apnea call for more frequent testing.

Guidelines also advise checking hematocrit before starting and not beginning testosterone when the baseline is already high, since treatment will likely push it higher (Bhasin et al., 2018; Mulhall et al., 2018). Many providers track related markers at the same visit, including estradiol and PSA, so the full picture stays visible.

The Bottom Line on High Hematocrit and TRT

High hematocrit on TRT is common, expected, and in most cases manageable. Testosterone raises red cell production, the number climbs, and a good monitoring plan catches it early (Fink et al., 2025; Neidhart et al., 2025).

The smarter approach is to watch your hematocrit and your blood pressure together, not your hematocrit alone. For men with diagnosed hypogonadism, high hematocrit on TRT is best handled by reading the full pattern of your labs and your provider's evaluation, not one alarming line on a report. A value above 54 percent is the level guidelines flag for action (Bhasin et al., 2018), but whether a high reading means adjusting, pausing, or staying the course is a decision to make with your provider, based on your full clinical picture rather than one number.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

What causes high hematocrit on TRT? 

Testosterone signals the bone marrow to make more red blood cells, a process called erythropoiesis, which raises hematocrit (Fink et al., 2025). In one 2025 study of 247 men, hematocrit rose about 4 percentage points on average among those with paired readings, and 5 percent of men passed 54 percent (Neidhart et al., 2025). The increase usually shows up within the first year.

Is high hematocrit on TRT dangerous? 

It can be, because thicker blood is linked to clotting and events like pulmonary embolism. In the TRAVERSE trial, testosterone didn't raise overall major cardiac events, 7.0 versus 7.3 percent, but it did show more pulmonary embolism and atrial fibrillation (Lincoff et al., 2023). Risk may be greatest when hematocrit and blood pressure climb together, so providers tend to watch both.

What hematocrit level is too high on testosterone? 

Clinical guidelines treat a hematocrit above 54 percent as the point that calls for action, such as a dose reduction or a blood draw (Bhasin et al., 2018; Mulhall et al., 2018). Below that, close monitoring is usually enough. Reference ranges vary by lab, so the trend matters more than any single reading.

How often should hematocrit be checked on TRT? 

Guidelines suggest a baseline check, another at three to six months, then once a year if levels are stable (Bhasin et al., 2018). Borderline values, dose changes, or risk factors like sleep apnea warrant more frequent testing.

Can you stay on testosterone with high hematocrit? 

It often can be, especially when blood pressure is controlled and the level stays below 54 percent. Above that point, a provider may lower the dose, change the formulation, or use therapeutic phlebotomy rather than stopping automatically (Mulhall et al., 2018). The right choice depends on your labs, symptoms, and provider evaluation.

Does switching testosterone formulation lower hematocrit? 

It can. Injectable testosterone, especially short-acting forms, tends to raise hematocrit more than transdermal gels or creams, which keep levels steadier (Fink et al., 2025). Moving from injections to a transdermal option is one common way to reduce the rise.

References

• FDA. Class-wide labeling changes for testosterone products. 2025

• Front Endocrinol (Lausanne). 2025;15:1496906

• J Clin Endocrinol Metab. 2018;103(5):1715-1744

• J Urol. 2018;200(2):423-432

• N Engl J Med. 2023;389(2):107-117

• Sex Med Rev. 2025;13(2):229-236